Alembic Pharma

BSE : 533573 | NSE : APLLTD

Industry : Pharmaceuticals | ISIN : INE901L01018 | FreeFloat : 30.00% | FnO : Yes | LotSize : 700


Intellectual Capital (IC)3,210.65
Net Worth (NW)5,237.55
Intrinsic Worth (IW)8,448.20
Market Cap (MC)14,577.12
Economic Value Added-161.86
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)38.00%
IC Gross Margin (EBITDA/IC)31.95%
IC Net Margin (NPT/IC)20.14%
Knowledge Turnover (Sales/IC)1.75
Market to Intrinsic Value (MC/IW)1.73

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 429.80Rs. 741.60
26 May 2022 ---- Rs. 738.25
-1.05     -0.14%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 746.18SellStrong Sell
KB > 50% : No50 DMA : Rs. 752.59
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
948.91
952.20
195.42
160.02
155.04
119.08
117.19
Sep-19
C
1240.87
1241.23
345.87
309.92
302.85
250.45
251.28
Dec-19
C
1209.13
1209.54
325.46
283.64
276.28
234.19
229.54
Mar-20
C
1206.83
1207.72
317.55
273.41
265.66
224.93
201.17
Jun-20
C
1341.32
1341.64
407.67
366.17
359.50
301.46
301.18
Sep-20
C
1457.10
1460.32
446.65
402.87
398.39
333.37
333.19
Dec-20
C
1314.33
1316.86
367.61
320.64
318.33
292.57
291.94
Mar-21
C
1280.39
1284.34
345.64
294.42
291.86
250.70
250.84
Jun-21
C
1326.03
1327.91
237.81
184.66
182.55
164.52
166.40
Sep-21
C
1292.32
1294.52
259.42
204.82
200.24
169.29
168.98
Dec-21
C
1271.70
1273.04
257.00
201.06
196.73
176.42
176.57
Mar-22
C
1415.74
1426.01
158.44
35.36
28.66
35.46
38.39
* C - Consolidated, S - Standalone